Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 95.71M 7.31B P/E ratio 2024 *
15.8x
P/E ratio 2025 * 10.2x
Enterprise value 38.66M 2.95B EV / Sales 2024 *
2.59x
EV / Sales 2025 * 2.12x
Free-Float
78.44%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.69%
1 week-7.15%
Current month-10.43%
1 month-8.61%
3 months+6.57%
6 months+40.38%
Current year+147.46%
More quotes
1 week
5.28
Extreme 5.28
6.41
1 month
5.28
Extreme 5.28
7.18
Current year
2.36
Extreme 2.3648
7.18
1 year
1.79
Extreme 1.79
7.18
3 years
1.79
Extreme 1.79
15.25
5 years
1.76
Extreme 1.7603
15.25
10 years
1.76
Extreme 1.7603
15.25
More quotes
Director TitleAgeSince
Founder 71 06/05/10
Chief Executive Officer 71 06/05/10
Director of Finance/CFO 52 31/12/14
Manager TitleAgeSince
Chief Executive Officer 71 06/05/10
Director/Board Member 77 30/09/15
Director/Board Member 71 20/07/16
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.69%-7.15%+105.63%+63.36%95.71M
-0.44%+6.44%-28.02%-57.58%17.22B
-1.25%+7.64%-40.89%-70.47%2.97B
-0.05%-1.50%+66.64%-25.24%1.47B
-0.71%-5.11%+33.29%+192.44%1.4B
-4.85%-6.42%-0.27% - 1.23B
-0.58%+2.57%+54.32%-45.49%1B
-0.61%+2.24%-25.63% - 767M
-0.23%+0.39%-38.70%-66.07%730M
+6.79%+9.81%+61.13%-36.66%668M
Average -0.12%+0.58%+18.75%-5.71% 2.76B
Weighted average by Cap. -0.54%+4.51%-14.59%-42.27%
See all sector performances
2024 *2025 *
Net sales 37.03M 2.83B 45.19M 3.45B
Net income 6.07M 463M 9.48M 724M
Net Debt - -
More financial data * Estimated data
Logo Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Employees
35
More about the company
Date Price Change Volume
10/09/24 5.840 $ +0.69% 77,293
09/09/24 5.800 $ +5.07% 191,775
06/09/24 5.520 $ -12.80% 378,548
05/09/24 6.330 $ +1.77% 104,160
04/09/24 6.220 $ -1.11% 135,575

Delayed Quote Nasdaq, September 10, 2024 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
5.840USD
Average target price
10.67USD
Spread / Average Target
+82.65%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW